The Greek NHS has approved the coverage of PGx-CNS product
Read More
iDNA Genomics Public Ltd successfully lists Bond 2028 on the CSE
Read More
Materials for Annual General Meeting of the Company 2023
Read More
Approval of financial statements 2022 and date set for AGM 2023
Read More
Issue of Corporate Bonds
Read More
Issue of 160.333 additional Shares following results of EGM 29.12.22
Read More
Results of the Extraordinary General Meeting of the Company
Read More
Updating the investing public regarding the 2022 Business Plan.
Read More
Calling of the Extraordinary General Meeting of the Company
Read More
Proud to announce our participation at ISPOR Europe 2022
Read More
The Interim Financial Statements have been approved
Read More
Successful application for coverage of PGx-CNS product
Read More